<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Medicine</journal-id><journal-title-group><journal-title xml:lang="en">Russian Medicine</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский медицинский журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-2106</issn><issn publication-format="electronic">2412-9100</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">107006</article-id><article-id pub-id-type="doi">10.17816/medjrf107006</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Reviews</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Научные обзоры</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Regulatory and legal regulation of medical care in the «cosmetology» profile in the Russian Federation</article-title><trans-title-group xml:lang="ru"><trans-title>Нормативно-правовое регулирование медицинской помощи по профилю «косметология» в Российской Федерации</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-7625-0503</contrib-id><contrib-id contrib-id-type="spin">8771-4990</contrib-id><name-alternatives><name xml:lang="en"><surname>Kubanov</surname><given-names>Alexey A.</given-names></name><name xml:lang="ru"><surname>Кубанов</surname><given-names>Алексей Алексеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>alex@cnikvi.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-0301-6310</contrib-id><contrib-id contrib-id-type="spin">6128-3388</contrib-id><name-alternatives><name xml:lang="en"><surname>Kolsanova</surname><given-names>Olga A.</given-names></name><name xml:lang="ru"><surname>Колсанова</surname><given-names>Ольга Александровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>к.м.н</p></bio><email>kosmetologso@mail.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2230-7292</contrib-id><contrib-id contrib-id-type="spin">1962-4682</contrib-id><name-alternatives><name xml:lang="en"><surname>Chertukhina</surname><given-names>Olga B.</given-names></name><name xml:lang="ru"><surname>Чертухина</surname><given-names>Ольга Борисовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), professor</p></bio><bio xml:lang="ru"><p>д.м.н., профессор</p></bio><email>o.b.chertukhina@samsmu.ru</email><xref ref-type="aff" rid="aff3"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">State Scientific Center of Dermatovenerology and Cosmetology</institution></aff><aff><institution xml:lang="ru">Государственный научный центр дерматовенерологии и косметологии</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Clinica New Life</institution></aff><aff><institution xml:lang="ru">Медицинская клиника «Нью Лайф»</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Samara State Medical University</institution></aff><aff><institution xml:lang="ru">Самарский государственный медицинский университет</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2022-11-23" publication-format="electronic"><day>23</day><month>11</month><year>2022</year></pub-date><volume>28</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>395</fpage><lpage>407</lpage><history><date date-type="received" iso-8601-date="2022-04-30"><day>30</day><month>04</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-10-25"><day>25</day><month>10</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Kubanov A.A., Kolsanova O.A., Chertukhina O.B.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Кубанов А.А., Колсанова О.А., Чертухина О.Б.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Kubanov A.A., Kolsanova O.A., Chertukhina O.B.</copyright-holder><copyright-holder xml:lang="ru">Кубанов А.А., Колсанова О.А., Чертухина О.Б.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2025-11-23"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref></license></permissions><self-uri xlink:href="https://medjrf.com/0869-2106/article/view/107006">https://medjrf.com/0869-2106/article/view/107006</self-uri><abstract xml:lang="en"><p>The theoretical and methodological bases of the present study are scientific works, theoretical and methodological developments, current publications of domestic scientists, official normative legal acts, and description of their application in the practical activities of medical organizations providing cosmetology services. This study aimed to examine studies that have focused on the most pressing issues of the legal regulation of medical care to the population of the Russian Federation in the field of «cosmetology», identify the main problems associated with the legal regulation of the industry, and summarize the proposals of medical organizations for its improvement.</p> <p>In the study, a survey study was conducted, which allowed researchers to identify and summarize the known literature on this topic, regardless of the publication type and study design. The study presents an analysis of the regulatory and legal regulations of the activities of employees and medical organizations providing services in the field of cosmetology. After completing the initial literature search, the authors analyzed, compared, summarized, and systematized the published information.</p> <p>The analysis made it possible to distribute the data obtained in several key areas of regulatory and legal regulation of domestic cosmetology, i.e., an excursion into history, regulatory and legal support for the activities of a cosmetology medical organization at the present stage, modern requirements for the activities of a doctor, in relation to medical cosmetology care. A content analysis was conducted on the use by medical organizations in the regions of the Russian Federation of the regulatory framework of the cosmetology industry, assessed its effect on the system of providing cosmetological care to the population at the present stage, identified several problems related to the legal regulation of the activities of medical cosmetology organizations and summarized proposals for its improvement.</p></abstract><trans-abstract xml:lang="ru"><p>Теоретической и методологической базой проведённого исследования служат научные труды, теоретико-методологические разработки, актуальные публикации отечественных учёных, официальные нормативно-правовые акты и описание их применения в практической деятельности медицинских организаций, оказывающих услуги по профилю «косметология».</p> <p>Целью исследования было изучение работ, посвящённых наиболее актуальным вопросам нормативно-правового регулирования оказания медицинской помощи населению Российской Федерации по профилю «косметология», выявление основных проблем, связанных с правовой регламентацией отрасли, и обобщение предложений медицинских организаций по её совершенствованию.</p> <p>Применена методология обзорного исследования, которая позволяет выявлять и обобщать известную литературу по данной теме независимо от вида публикации и дизайна исследования. Представлен анализ нормативно-правового регулирования деятельности сотрудников и медицинских организаций, оказывающих услуги в сфере косметологии.</p> <p>Выполнив первоначальный поиск литературы, авторы провели анализ, сопоставление, обобщение и систематизацию опубликованной информации. Это позволило распределить полученные данные по нескольким ключевым направлениям: нормативно-правовое регулирование отечественной косметологии — экскурс в историю; современные требования к деятельности врача применительно к медицинской косметологической помощи.</p> <p>Авторы провели контент-анализ использования медицинскими организациями регионов Российской Федерации нормативно-правовой базы отрасли «косметология»; оценили её влияние на систему оказания косметологической помощи населению на современном этапе; выявили ряд проблем, связанных с правовой регламентацией деятельности медицинских организаций косметологического профиля; обобщили предложения по её совершенствованию.</p></trans-abstract><kwd-group xml:lang="en"><kwd>regulatory and legal regulation of medical care in the «cosmetology» profile</kwd><kwd>cosmetic services</kwd><kwd>requirements for the activities of a medical organization and a cosmetologist</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>нормативно-правовое регулирование медицинской помощи по профилю «косметология»</kwd><kwd>косметические услуги</kwd><kwd>требования к деятельности медицинской организации и врача-косметолога</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">Alieva AM, Reznik EV, Hasanova ET, et al. Clinical value of blood biomarkers in patients with chronic heart failure. The Russian Archives of Internal Medicine. 2018;8(5):333–345. (In Russ). doi: 10.20514 / 2226-6704-2018-8-5-333-345</mixed-citation><mixed-citation xml:lang="ru">Алиева А.М., Резник Е.В., Гасанова Э.Т., и др. Клиническое значение определения биомаркеров крови у больных с хронической сердечной недостаточностью // Архивъ внутренней медицины. 2018. Т. 8, № 5. С. 333–345. doi: 10.20514/2226-6704-2018-8-5-333-345</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">Alieva AM, Pinchuk TV, Almazova II, et al. Сlinical value of blood biomarker ST2 in patients with chronic heart failure. Consilium Medicum. 2021;23(6):522–526. (In Russ). doi: 10.26442/20751753.2021.6.200606</mixed-citation><mixed-citation xml:lang="ru">Алиева А.М., Пинчук Т.В., Алмазова И.И., и др. Клиническое значение определения биомаркера крови ST2 у больных с хронической сердечной недостаточностью // Consilium Medicum. 2021. Т. 23, № 6. С. 522–526. doi: 10.26442/20751753.2021.6.200606</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">Alieva AM, Baykova IE, Kislyakov VA. Galectin-3: diagnostic and prognostic value in patients with chronic heart failure. Therapevti cheskii arkhiv. 2019;91(9):145–149. (In Russ). doi: 10.26442/00403660.2019.09.000226</mixed-citation><mixed-citation xml:lang="ru">Алиева А.М., Байкова И.Е., Кисляков В.А., и др. Галектин-3: диагностическая и прогностическая ценность определения у пациентов с хронической сердечной недостаточностью // Терапевтический архив. 2019. Т. 91, № 9. С. 145–149. doi: 10.26442/00403660.2019.09.000226</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">Alieva AM, Almazova II, Pinchuk TV. Fractalkin and cardiovascular diseases. Consilium Medicum. 2020;22(5):83–86. (In Russ). doi: 10.26442/20751753.2020.5.200186</mixed-citation><mixed-citation xml:lang="ru">Алиева А.М., Алмазова И.И., Пинчук Т.В., и др. Фракталкин и сердечно-сосудистые заболевания // Consilium Medicum. 2020. Т. 22, № 5. С. 83–86. doi: 10.26442/20751753.2020.5.200186</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">Kuro-o M, Matsumura Y, Aizawa H, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(6655):45–51. doi: 10.1038/36285</mixed-citation><mixed-citation xml:lang="ru">Kuro-o M., Matsumura Y., Aizawa H., et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing // Nature. 1997. Vol. 390, N. 6655. P. 45–51. doi: 10.1038/36285</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">Timoshchenko OV, Nikitin YuP. Klotho protein and atherosclerosis. Ateroscleroz. 2017;13(4):38–41. (In Russ). doi: 10.15372/ATER20170406</mixed-citation><mixed-citation xml:lang="ru">Тимощенко О.В., Никитин Ю.П. Белок Клото и атеросклероз // Атеросклероз. 2017. Т. 13, №4. С. 38-41. doi: 10.15372/ATER20170406</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">Masuda H, Chikuda H, Suga T, et al. Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice. Mech Ageing Dev. 2005;126(12):1274–1283. doi: 10.1016/j.mad.2005.07.007</mixed-citation><mixed-citation xml:lang="ru">Masuda H., Chikuda H., Suga T., et al. Regulation of multiple ageing-like phenotypes by inducible klotho gene expression in klotho mutant mice // Mech Ageing Dev. 2005. Vol. 126, N. 12. P. 1274–1283. doi: 10.1016/j.mad.2005.07.007</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">Bi X, Yang K, Zhang B, Zhao J. The protective role of Klotho in CKD-associated cardiovascular disease. Kidney Dis. 2020;6(6):395–406. doi: 10.1159/000509369</mixed-citation><mixed-citation xml:lang="ru">Bi X., Yang K., Zhang B., Zhao J. The protective role of Klotho in CKD-associated cardiovascular disease // Kidney Dis. 2020. Vol. 6, N. 6. P. 395–406. doi: 10.1159/000509369</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">Matsumura Y, Aizawa H, Shiraki-Iida T, et al. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein. Biochem Biophys Res Commun. 1998;242(3):626–630. doi: 10.1006/bbrc.1997.8019</mixed-citation><mixed-citation xml:lang="ru">Matsumura Y., Aizawa H., Shiraki-Iida T., et al. Identification of the human klotho gene and its two transcripts encoding membrane and secreted klotho protein // Biochem Biophys Res Commun. 1998. Vol. 242, N. 3. P. 626–630. doi: 10.1006/bbrc.1997.8019</mixed-citation></citation-alternatives></ref><ref id="B10"><label>10.</label><citation-alternatives><mixed-citation xml:lang="en">Bloch L, Sineshchekova O, Reichenbach D, et al. Klotho is a substrate for alpha-, beta- and gamma-secretase. FEBS Lett. 2009;583(19):3221–3224. doi: 10.1016/j.febslet.2009.09.009</mixed-citation><mixed-citation xml:lang="ru">Bloch L., Sineshchekova O., Reichenbach D., et al. Klotho is a substrate for alpha-, beta- and gamma-secretase // FEBS Lett. 2009. Vol. 583, N 19. P. 3221–3224. doi: 10.1016/j.febslet.2009.09.009</mixed-citation></citation-alternatives></ref><ref id="B11"><label>11.</label><citation-alternatives><mixed-citation xml:lang="en">Veronesi F, Borsari V, Cherubini A, Fini M. Association of Klotho with physical performance and frailty in middle-aged and older adults: a systematic review. Exp Gerontol. 2021;154:111518. doi: 10.1016/j.exger.2021.111518</mixed-citation><mixed-citation xml:lang="ru">Veronesi F., Borsari V., Cherubini A., Fini M. Association of Klotho with physical performance and frailty in middle-aged and older adults: a systematic review // Exp Gerontol. 2021. Vol. 154. P. 111518. doi: 10.1016/j.exger.2021.111518</mixed-citation></citation-alternatives></ref><ref id="B12"><label>12.</label><citation-alternatives><mixed-citation xml:lang="en">Tomo S, Birdi A, Yadav D, et al. Klotho: a possible role in the pathophysiology of nephrotic syndrome. EJIFCC. 2022;33(1):3–10.</mixed-citation><mixed-citation xml:lang="ru">Tomo S., Birdi A., Yadav D., et al. Klotho: a possible role in the pathophysiology of nephrotic syndrome // EJIFCC. 2022. Vol. 33, N 1. P. 3–10.</mixed-citation></citation-alternatives></ref><ref id="B13"><label>13.</label><citation-alternatives><mixed-citation xml:lang="en">Van Husen M, Fischer AK, Lehnhardt A, et al. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int. 2010;78(2):200–206. doi: 10.1038/ ki.2010.107</mixed-citation><mixed-citation xml:lang="ru">Van Husen M., Fischer A.K., Lehnhardt A., et al. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease // Kidney Int. 2010. Vol. 78, N 2. P. 200–206. doi: 10.1038/ ki.2010.107</mixed-citation></citation-alternatives></ref><ref id="B14"><label>14.</label><citation-alternatives><mixed-citation xml:lang="en">Andrukhova O, Smorodchenko A, Egerbacher M, et al. FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J. 2014;33(3):229–246. doi: 10.1002/embj.201284188</mixed-citation><mixed-citation xml:lang="ru">Andrukhova O., Smorodchenko A., Egerbacher M., et al. FGF23 promotes renal calcium reabsorption through the TRPV5 channel // EMBO J. 2014. Vol. 33, N 3. P. 229–246. doi: 10.1002/embj.201284188</mixed-citation></citation-alternatives></ref><ref id="B15"><label>15.</label><citation-alternatives><mixed-citation xml:lang="en">Yamazaki Y, Imura A, Urakawa I, et al. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: age-dependent change of soluble alpha-Klotho levels in healthy subjects. Biochem Biophys Res Commun. 2010;398(3):513–518. doi: 10.1016/j.bbrc.2010.06.110.</mixed-citation><mixed-citation xml:lang="ru">Yamazaki Y., Imura A., Urakawa I., et al. Establishment of sandwich ELISA for soluble alpha-Klotho measurement: аge-dependent change of soluble alpha-Klotho levels in healthy subjects // Biochem Biophys Res Commun. 2010. Vol. 398, N 3. P. 513–518. doi: 10.1016/j.bbrc.2010.06.110</mixed-citation></citation-alternatives></ref><ref id="B16"><label>16.</label><citation-alternatives><mixed-citation xml:lang="en">Pedersen L, Pedersen SM, Brasen CL, Rasmussen LM. Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays. Clin Biochem. 2013;46(12):1079–1083. doi: 10.1016/j.clinbiochem.2013.05.046</mixed-citation><mixed-citation xml:lang="ru">Pedersen L., Pedersen S.M., Brasen C.L., Rasmussen L.M. Soluble serum Klotho levels in healthy subjects. Comparison of two different immunoassays // Clin Biochem. 2013. Vol. 46, N 12. P. 1079–1083. doi: 10.1016/j.clinbiochem.2013.05.046</mixed-citation></citation-alternatives></ref><ref id="B17"><label>17.</label><citation-alternatives><mixed-citation xml:lang="en">Tyurenkov IN, Perfilova VN, Nesterova AA, Glinka Y. Klotho protein and cardio-vascular system. Biochemistry (Moscow). 2021;86(2):158–174. (In Russ). doi: 10.31857/S0320972521020020</mixed-citation><mixed-citation xml:lang="ru">Тюренков И.Н., Перфилова В.Н., Нестерова А.А., Глинка Г.Ю. Белок Клото и сердечно-сосудистая система // Биохимия. 2021. Т. 86, № 2. С. 158–174. doi: 10.31857/S0320972521020020</mixed-citation></citation-alternatives></ref><ref id="B18"><label>18.</label><citation-alternatives><mixed-citation xml:lang="en">Kim J, Hwang K, Park K, et al. Biological role of anti-aging pro tein Klotho. J Lifestyle Med. 2015;5(1):1–6. doi: 10.15280/jlm.2015.5.1.1</mixed-citation><mixed-citation xml:lang="ru">Kim J., Hwang K., Park K., et al. Biological role of anti-aging protein Klotho // J Lifestyle Med. 2015. Vol. 5, N 1. P. 1–6. doi: 10.15280/jlm.2015.5.1.1</mixed-citation></citation-alternatives></ref><ref id="B19"><label>19.</label><citation-alternatives><mixed-citation xml:lang="en">Dalton GD, Xie J, An S, Huang C. New Insights into the Mechanism of Action of Soluble Klotho. Front Endocrinol (Lausanne). 2017; 8:323. doi: 10.3389/fendo.2017.00323</mixed-citation><mixed-citation xml:lang="ru">Dalton G.D., Xie J., An S., Huang C. New insights into the mechanism of action of soluble Klotho // Front Endocrinol (Lausanne). 2017. Vol. 8. P. 323. doi: 10.3389/fendo.2017.00323</mixed-citation></citation-alternatives></ref><ref id="B20"><label>20.</label><citation-alternatives><mixed-citation xml:lang="en">Doi S, Zou Y, Togao O, et al. Klotho inhibits transforming growth factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011;286(10):8655–8665. doi: 10.1074/jbc.M110.174037</mixed-citation><mixed-citation xml:lang="ru">Doi S., Zou Y., Togao O., et al. Klotho inhibits transforming growth factor-β1 (TGF-β1) signaling and suppresses renal fibrosis and cancer metastasis in mice // J Biol Chem. 2011. Vol. 286, N 10. P. 8655–8665. doi: 10.1074/jbc.M110.174037</mixed-citation></citation-alternatives></ref><ref id="B21"><label>21.</label><citation-alternatives><mixed-citation xml:lang="en">Olejnik A, Franczak A, Krzywonos-Zawadzka A, et al. The biological role of Klotho protein in the development of cardiovascular diseases. Biomed Res Int. 2018;5171945. doi: 10.1155/2018/5171945</mixed-citation><mixed-citation xml:lang="ru">Olejnik A., Franczak A., Krzywonos-Zawadzka A., et al. The biological role of Klotho protein in the development of cardiovascular diseases // Biomed Res Int. 2018. P. 5171945. doi: 10.1155/2018/5171945</mixed-citation></citation-alternatives></ref><ref id="B22"><label>22.</label><citation-alternatives><mixed-citation xml:lang="en">Morshneva AV. FoxO transcription factors as multifunctional cell regulators. Tsitologiya. 2020;62(10):687–698. (In Russ). doi: 10.31857/S0041377120100041</mixed-citation><mixed-citation xml:lang="ru">Моршнева А.В. Транскрипционные факторы FoxO как много функциональные регуляторы клеточных процессов // Цито логия. 2020. Т. 62, № 10. С. 687–698. doi: 10.31857/S0041377120100041</mixed-citation></citation-alternatives></ref><ref id="B23"><label>23.</label><citation-alternatives><mixed-citation xml:lang="en">Cui W, Leng B, Wang G. Klotho protein inhibits H2O2-induced oxidative injury in endothelial cells via regulation of PI3K/AKT/Nrf2/HO-1 pathways. Can J Physiol Pharmacol. 2019;97(5):370–376. doi: 10.1139/cjpp-2018-0277</mixed-citation><mixed-citation xml:lang="ru">Cui W., Leng B., Wang G. Klotho protein inhibits H2O2-induced oxidative injury in endothelial cells via regulation of PI3K/AKT/Nrf2/HO-1 pathways // Can J Physiol Pharmacol. 2019. Vol. 97, N 5. P. 370–376. doi: 10.1139/cjpp-2018-0277</mixed-citation></citation-alternatives></ref><ref id="B24"><label>24.</label><citation-alternatives><mixed-citation xml:lang="en">Yao Y, Wang Y, Zhang Y, Liu C. Klotho ameliorates oxidized low-density lipoprotein (ox-LDL)-induced oxidative stress via re gulating LOX-1 and PI3K/Akt/eNOS pathways. Lipids Health Dis. 2017;16(1):77. doi: 10.1186/s12944-017-0447-0</mixed-citation><mixed-citation xml:lang="ru">Yao Y., Wang Y., Zhang Y., Liu C. Klotho ameliorates oxidized low-density lipoprotein (ox-LDL)-induced oxidative stress via regulating LOX-1 and PI3K/Akt/eNOS pathways // Lipids Health Dis. 2017. Vol. 16, N 1. P. 77. doi: 10.1186/s12944-017-0447-0.</mixed-citation></citation-alternatives></ref><ref id="B25"><label>25.</label><citation-alternatives><mixed-citation xml:lang="en">Takenaka T, Kobori H, Miyazaki T, et al. Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes. Acta Physiol (Oxf). 2019;225(2):e13190. doi: 10.1111/apha.13190</mixed-citation><mixed-citation xml:lang="ru">Takenaka T., Kobori H., Miyazaki T., et al. Klotho protein supplementation reduces blood pressure and renal hypertrophy in db/db mice, a model of type 2 diabetes // Acta Physiol (Oxf). 2019. Vol. 225, N 2. P. e13190. doi: 10.1111/apha.13190</mixed-citation></citation-alternatives></ref><ref id="B26"><label>26.</label><citation-alternatives><mixed-citation xml:lang="en">Lim SW, Jin L, Luo K, et al. Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress. Cell Death Dis. 2017;8(8): e2972. doi: 10.1038/cddis.2017.365</mixed-citation><mixed-citation xml:lang="ru">Lim S.W., Jin L., Luo K., et al. Klotho enhances FoxO3-mediated manganese superoxide dismutase expression by negatively regulating PI3K/AKT pathway during tacrolimus-induced oxidative stress // Cell Death Dis. 2017. Vol. 8, N 8. P. e2972. doi: 10.1038/cddis.2017.365</mixed-citation></citation-alternatives></ref><ref id="B27"><label>27.</label><citation-alternatives><mixed-citation xml:lang="en">Yamamoto M, Clark JD, Pastor JV, et al. Regulation of oxi dative stress by the anti-aging hormone klotho. J Biol Chem. 2005;280(45):38029–38034. doi: 10.1074/jbc.m509039200</mixed-citation><mixed-citation xml:lang="ru">Yamamoto M., Clark J.D., Pastor J.V., et al. Regulation of oxidative stress by the anti-aging hormone klotho // J Biol Chem. 2005. Vol. 280, N 45. P. 38029–38034. doi: 10.1074/jbc.m509039200</mixed-citation></citation-alternatives></ref><ref id="B28"><label>28.</label><citation-alternatives><mixed-citation xml:lang="en">Thurston RD, Larmonier CB, Majewski PM, et al. Downregulation of aging-related Klotho gene in experimental colitis: the role of TNF and IFN-γ Gastroenterology. 2010;138(4):1384–1394.e2. doi: 10.1053/j.gastro.2009.12.002</mixed-citation><mixed-citation xml:lang="ru">Thurston R.D., Larmonier C.B., Majewski P.M., et al. Downre gu lation of aging-related Klotho gene in experimental colitis: the role of TNF and IFN-γ // Gastroenterology. 2010. Vol. 138, N 4. P. 1384–1394. doi: 10.1053/j.gastro.2009.12.002</mixed-citation></citation-alternatives></ref><ref id="B29"><label>29.</label><citation-alternatives><mixed-citation xml:lang="en">Mitobe M, Yoshida T, Sugiura H, et al. Oxidative stress decreases klotho expression in a mouse kidney cell line. Nephron Exp Nephrol. 2005;101(2):e67–e74. doi: 10.1159/000086500</mixed-citation><mixed-citation xml:lang="ru">Mitobe M., Yoshida T., Sugiura H., et al. Oxidative stress decreases klotho expression in a mouse kidney cell line // Nephron Exp Nephrol. 2005. Vol. 101, N 2. P. e67–e74. doi: 10.1159/000086500</mixed-citation></citation-alternatives></ref><ref id="B30"><label>30.</label><citation-alternatives><mixed-citation xml:lang="en">Oh HJ, Nam BY, Lee MJ, et al. Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation. Perit Dial Int. 2015;35(1):43–51. doi: 10.3747/pdi.2013.00150</mixed-citation><mixed-citation xml:lang="ru">Oh H.J., Nam B.Y., Lee M.J., et al. Decreased circulating klotho levels in patients undergoing dialysis and relationship to oxidative stress and inflammation // Perit Dial Int. 2015. Vol. 35, N 1. P. 43–51. doi: 10.3747/pdi.2013.00150</mixed-citation></citation-alternatives></ref><ref id="B31"><label>31.</label><citation-alternatives><mixed-citation xml:lang="en">Kusaba T, Okigaki M, Matui A, et al. Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity. Proc Natl Acad Sci USA. 2010;107(45):19308–19313. doi: 10.1073/pnas.1008544107</mixed-citation><mixed-citation xml:lang="ru">Kusaba T., Okigaki M., Matui A., et al. Klotho is associated with VEGF receptor-2 and the transient receptor potential canonical-1 Ca2+ channel to maintain endothelial integrity // Proc Natl Acad Sci USA. 2010. Vol. 107, N 45. P. 19308–19313. doi: 10.1073/pnas.1008544107</mixed-citation></citation-alternatives></ref><ref id="B32"><label>32.</label><citation-alternatives><mixed-citation xml:lang="en">Semba RD, Cappola AR, Sun K, et al. Plasma klotho and cardiovascular disease in adults. J Am Geriatr Soc. 2011;59(9):1596–1601. doi: 10.1111/j.1532-5415.2011.03558.x</mixed-citation><mixed-citation xml:lang="ru">Semba R.D., Cappola A.R., Sun K., et al. Plasma klotho and cardiovascular disease in adults // J Am Geriatr Soc. 2011. Vol. 59, N 9. P. 1596–1601. doi: 10.1111/j.1532-5415.2011. 03558.x</mixed-citation></citation-alternatives></ref><ref id="B33"><label>33.</label><citation-alternatives><mixed-citation xml:lang="en">Kokkinaki M, Abu-Asab M, Gunawardena N, et al. Klotho regulates retinal pigment epithelial functions and protects against oxidative stress. J Neurosci. 2013;33(41):16346–16359. doi: 10.1523/JNEUROSCI.0402-13.2013</mixed-citation><mixed-citation xml:lang="ru">Kokkinaki M., Abu-Asab M., Gunawardena N., et al. Klotho regulates retinal pigment epithelial functions and protects against oxidative stress // Neurosci. 2013. Vol. 33, N 41. P. 16346–16359. doi: 10.1523/JNEUROSCI.0402-13.2013</mixed-citation></citation-alternatives></ref><ref id="B34"><label>34.</label><citation-alternatives><mixed-citation xml:lang="en">Zhao Y, Meng C, Wang Y, et al. IL-1β inhibits β-Klotho expression and FGF19 signaling in hepatocytes. Am J Physiol Endocrinol Metab. 2016;310(4):E289–300. doi: 10.1152/ajpendo.00356.2015</mixed-citation><mixed-citation xml:lang="ru">Zhao Y., Meng C., Wang Y., et al. IL-1β inhibits β-Klotho expression and FGF19 signaling in hepatocytes // Am J Physiol Endocrinol Metab. 2016. Vol. 310, N 4. P. E289–300. doi: 10.1152/ajpendo.00356.2015</mixed-citation></citation-alternatives></ref><ref id="B35"><label>35.</label><citation-alternatives><mixed-citation xml:lang="en">Graham SE, Clarke SL, Wu KH, et al. The power of genetic diversity in genome-wide association studies of lipids. Nature. 2021;600(7890):675–679. doi: 10.1038/s41586-021-04064-3</mixed-citation><mixed-citation xml:lang="ru">Graham S.E., Clarke S.L., Wu K.H., et al. The power of genetic diversity in genome-wide association studies of lipids // Nature. 2021. Vol. 600, N 7890. P. 675–679. doi: 10.1038/s41586-021-04064-3</mixed-citation></citation-alternatives></ref><ref id="B36"><label>36.</label><citation-alternatives><mixed-citation xml:lang="en">Arking DE, Becker DM, Yanek LR, et al. KLOTHO allele status and the risk of early-onset occult coronary artery disease. Am J Hum Genet. 2003;72(5):1154–1161. doi: 10.1086/375035</mixed-citation><mixed-citation xml:lang="ru">Arking D.E., Becker D.M., Yanek L.R., et al. KLOTHO allele status and the risk of early-onset occult coronary artery disease // Hum Genet. 2003. Vol. 72, N 5. P. 1154–1161. doi: 10.1086/375035</mixed-citation></citation-alternatives></ref><ref id="B37"><label>37.</label><citation-alternatives><mixed-citation xml:lang="en">Majumdar V, Nagaraja D, Christopher R. Association of the functional KL-VS variant of Klotho gene with early-onset ischemic stroke. Biochem Biophys Res Commun. 2010;403(3-4):412–416. doi: 10.1016/j.bbrc.2010.11.045</mixed-citation><mixed-citation xml:lang="ru">Majumdar V., Nagaraja D., Christopher R. Association of the functional KL-VS variant of Klotho gene with early-onset ischemic stroke // Biochem Biophys Res Commun. 2010. Vol. 403, N 3-4. P. 412–416. doi: 10.1016/j.bbrc.2010.11.045</mixed-citation></citation-alternatives></ref><ref id="B38"><label>38.</label><citation-alternatives><mixed-citation xml:lang="en">Oguro R, Kamide K, Kokubo Y, et al. Association of carotid atherosclerosis with genetic polymorphisms of the klotho gene in patients with hypertension. Geriatr Gerontol Int. 2010;10(4):311–318. doi: 10.1111/j.1447-0594.2010.00612</mixed-citation><mixed-citation xml:lang="ru">Oguro R., Kamide K., Kokubo Y., et al. Association of carotid atherosclerosis with genetic polymorphisms of the klotho gene in patients with hypertension // Geriatr Gerontol Int. 2010. Vol. 10, N 4. P. 311–318. doi: 10.1111/j.1447-0594.2010. 00612.x</mixed-citation></citation-alternatives></ref><ref id="B39"><label>39.</label><citation-alternatives><mixed-citation xml:lang="en">Imamura A, Okumura K, Ogawa Y, et al. Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese. Clin Chim Acta. 2006;371(1-2):66–70. doi: 10.1016/j.cca.2006.02.021</mixed-citation><mixed-citation xml:lang="ru">Imamura A., Okumura K., Ogawa Y., et al. Klotho gene polymorphism may be a genetic risk factor for atherosclerotic coronary artery disease but not for vasospastic angina in Japanese // Clin Chim Acta. 2006. Vol. 371, N 1-2. P. 66–70. doi: 10.1016/j.cca.2006.02.021</mixed-citation></citation-alternatives></ref><ref id="B40"><label>40.</label><citation-alternatives><mixed-citation xml:lang="en">Telci D, Dogan AU, Ozbek E, et al. KLOTHO gene polymorphism of G395A is associated with kidney stones. Am J Nephrol. 2011;33(4):337–343. doi: 10.1159/000325505</mixed-citation><mixed-citation xml:lang="ru">Telci D., Dogan A.U., Ozbek E., et al. KLOTHO gene polymorphism of G395A is associated with kidney stones // Am J Nephrol. 2011. Vol. 33, N 4. P. 337–343. doi: 10.1159/000325505</mixed-citation></citation-alternatives></ref><ref id="B41"><label>41.</label><citation-alternatives><mixed-citation xml:lang="en">Kawano KI, Ogata N, Chiano M, et al. Klotho gene polymorphisms associated with bone density of aged postmenopausal women. J Bone Miner Res. 2002;17(10):1744–1751. doi: 10.1359/jbmr.2002.17.10.1744</mixed-citation><mixed-citation xml:lang="ru">Kawano K.I., Ogata N., Chiano M., et al. Klotho gene polymorphisms associated with bone density of aged postmenopausal women // J Bone Miner Res. 2002. Vol. 1, N 10. P. 1744–1751. doi: 10.1359/jbmr.2002.17.10.1744</mixed-citation></citation-alternatives></ref><ref id="B42"><label>42.</label><citation-alternatives><mixed-citation xml:lang="en">Majumdar V, Jose D, Christopher R. Influence of Klotho genotypes on plasma NO(x) levels in South Indian population. Thromb Res. 2011;128(3):251–255. doi: 10.1016/j.thromres.2011.04.002</mixed-citation><mixed-citation xml:lang="ru">Majumdar V., Jose D., Christopher R. Influence of Klotho genotypes on plasma NO(x) levels in South Indian population // Thromb Res. 2011. Vol. 128, N 3. P. 251–255. doi: 10.1016/j.thromres.2011.04.002</mixed-citation></citation-alternatives></ref><ref id="B43"><label>43.</label><citation-alternatives><mixed-citation xml:lang="en">Pavlatou MG, Remaley AT, Gold PW. Klotho: a humeral mediator in CSF and plasma that influences longevity and susceptibility to multiple complex disorders, including depression. Transl Psychiatry. 2016;6(8):e876. doi: 10.1038/tp.2016.135</mixed-citation><mixed-citation xml:lang="ru">Pavlatou M.G., Remaley A.T., Gold P.W. Klotho: a humeral mediator in CSF and plasma that influences longevity and suscep tibility to multiple complex disorders, including depression // Transl Psychiatry. 2016. Vol. 6, N 8. P. e876. doi: 10.1038/tp.2016.135</mixed-citation></citation-alternatives></ref><ref id="B44"><label>44.</label><citation-alternatives><mixed-citation xml:lang="en">Rhee EJ, Oh KW, Yun EJ, et al. Relationship between polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene with glucose metabolism and cardiovascular risk factors in Korean women. J Endocrinol Invest. 2006;29(7):613–618. doi: 10.1007/BF03344160</mixed-citation><mixed-citation xml:lang="ru">Rhee E.J., Oh K.W., Yun E.J., et al. Relationship between polymorphisms G395A in promoter and C1818T in exon 4 of the KLOTHO gene with glucose metabolism and cardiovascular risk factors in Korean women // J Endocrinol Invest. 2006. Vol. 29, N 7. P. 613–618. doi: 10.1007/BF03344160</mixed-citation></citation-alternatives></ref><ref id="B45"><label>45.</label><citation-alternatives><mixed-citation xml:lang="en">Elghoroury EA, Fadel FI, Elshamaa MF, et al. Klotho G-395A gene polymorphism: impact on progression of end-stage renal disease and development of cardiovascular complications in children on dialysis. Pediatr Nephrol. 2018;33(6):1–9. doi: 10.1007/s00467-017-3877-z</mixed-citation><mixed-citation xml:lang="ru">Elghoroury E.A., Fadel F.I., Elshamaa M.F., et al. Klotho G-395A gene polymorphism: impact on progression of end-stage renal disease and development of cardiovascular complications in children on dialysis // Pediatr Nephrol. 2018. Vol. 33, N 6. P. 1–9. doi: 10.1007/s00467-017-3877-z</mixed-citation></citation-alternatives></ref><ref id="B46"><label>46.</label><citation-alternatives><mixed-citation xml:lang="en">Valdivielso JM, Bozic M, Galimudi RK, et al. Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease. Nephrol Dial Transplant. 2019;34(12):2079–2088. doi: 10.1093/ndt/gfy207</mixed-citation><mixed-citation xml:lang="ru">Valdivielso J.M., Bozic M., Galimudi R.K., et al. Association of the rs495392 Klotho polymorphism with atheromatosis progression in patients with chronic kidney disease // Nephrol Dial Transplant. 2019. Vol. 34, N 12. P. 2079–2088. doi: 10.1093/ndt/gfy207</mixed-citation></citation-alternatives></ref><ref id="B47"><label>47.</label><citation-alternatives><mixed-citation xml:lang="en">Keles N, Caliskan M, Dogan B, et al. Is low serum Klotho level associated with alterations in coronary flow reserve? Echocardio graphy. 2016;33(6):881–888. doi: 10.1111/echo.13176</mixed-citation><mixed-citation xml:lang="ru">Keles N., Caliskan M., Dogan B., et al. Is low serum Klotho level associated with alterations in coronary flow reserve? // Echocardiography. 2016. Vol. 33, N 6. P. 881–888. doi: 10.1111/echo.13176</mixed-citation></citation-alternatives></ref><ref id="B48"><label>48.</label><citation-alternatives><mixed-citation xml:lang="en">Kresovich JK, Bulka CM. Low serum Klotho associated with all-cause mortality among a nationally representative sample of Ameri can adults. J Gerontol A Biol Sci Med Sci. 2022;77(3):452–456. doi: 10.1093/gerona/glab308</mixed-citation><mixed-citation xml:lang="ru">Kresovich J.K., Bulka C.M. Low serum Klotho associated with all-cause mortality among a nationally representative sample of American adults // Gerontol A Biol Sci Med Sci. 2022. Vol. 77, N 3. P. 452–456. doi: 10.1093/gerona/glab308</mixed-citation></citation-alternatives></ref><ref id="B49"><label>49.</label><citation-alternatives><mixed-citation xml:lang="en">Martin-Nunez E, Donate-Correa J, Lopez-Castillo A, et al. Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease. Clin Sci (Lond). 2017;131(21):2601–2609. doi: 10.1042/CS20171242</mixed-citation><mixed-citation xml:lang="ru">Martin-Nunez E., Donate-Correa J., Lopez-Castillo A., et al. Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease // Clin Sci (Lond). 2017. Vol. 131, N 21. P. 2601–2609. doi: 10.1042/CS20171242</mixed-citation></citation-alternatives></ref><ref id="B50"><label>50.</label><citation-alternatives><mixed-citation xml:lang="en">Keles N, Caliskan M, Dogan B, et al. Low serum level of Klotho is an early predictor of atherosclerosis. Tohoku J Exp Med. 2015;237(1):17–23. doi: 10.1620/tjem.237.17</mixed-citation><mixed-citation xml:lang="ru">Keles N., Caliskan M., Dogan B., et al. Low serum level of Klotho is an early predictor of atherosclerosis // Tohoku Exp Med. 2015. Vol. 237, N 1. P. 17–23. doi: 10.1620/tjem.237.17</mixed-citation></citation-alternatives></ref><ref id="B51"><label>51.</label><citation-alternatives><mixed-citation xml:lang="en">Kazemi Fard T, Ahmadi R, Akbari T, et al. Klotho, FOXO1 and cytokines associations in patients with coronary artery disease. Cytokine. 2021;141:155443. doi: 10.1016/j.cyto.2021.155443</mixed-citation><mixed-citation xml:lang="ru">Kazemi Fard T., Ahmadi R., Akbari T., et al. Klotho, FOXO1 and cytokines associations in patients with coronary artery disease // Cytokine. 2021. Vol. 141. P. 155443. doi: 10.1016/j.cyto.2021.155443</mixed-citation></citation-alternatives></ref><ref id="B52"><label>52.</label><citation-alternatives><mixed-citation xml:lang="en">Corsetti G, Pasini E, Scarabelli TM, et al. Decreased expression of Klotho in cardiac atria biopsy samples from patients at higher risk of atherosclerotic cardiovascular disease. J Geriatr Cardiol. 2016;13(8):701–711. doi: 10.11909/j.issn.1671-5411.2016.08.009</mixed-citation><mixed-citation xml:lang="ru">Corsetti G., Pasini E., Scarabelli T.M., et al. Decreased expression of Klotho in cardiac atria biopsy samples from patients at higher risk of atherosclerotic cardiovascular disease // J Geriatr Cardiol. 2016. Vol. 13, N 8. P. 701–711. doi: 10.11909/j.issn.1671-5411.2016.08.009</mixed-citation></citation-alternatives></ref><ref id="B53"><label>53.</label><citation-alternatives><mixed-citation xml:lang="en">Wei N, Zhang R, Zhu Z, et al. Adropin and Irisin deficiencies are associated with presence of diagonal earlobe crease in CAD pa tients. Front Cardiovasc Med. 2021;8:719763. doi: 10.3389/fcvm.2021.719763</mixed-citation><mixed-citation xml:lang="ru">Wei N., Zhang R., Zhu Z., et al. Adropin and irisin deficiencies are associated with presence of diagonal earlobe crease in CAD patients // Front Cardiovasc Med. 2021. Vol. 8. P. 719763. doi: 10.3389/fcvm.2021.719763</mixed-citation></citation-alternatives></ref><ref id="B54"><label>54.</label><citation-alternatives><mixed-citation xml:lang="en">Wang J, Zhu ZF, Liu FQ, et al. Patients with earlobe crease may associate with lower concentration of the age-suppressing hormone Klotho. Int J Gen Med. 2021;14:8797–8803. doi: 10.2147/IJGM.S300309</mixed-citation><mixed-citation xml:lang="ru">Wang J., Zhu Z.F., Liu F.Q., et al. Patients with earlobe crease may associate with lower concentration of the age-suppressing hormone Klotho // Int J Gen Med. 2021. Vol. 14. P. 8797–8803. doi: 10.3389/fcvm.2021.719763</mixed-citation></citation-alternatives></ref><ref id="B55"><label>55.</label><citation-alternatives><mixed-citation xml:lang="en">Martin-Nunez E, Perez-Castro A, Tagua VG, et al. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease. Sci Rep. 2022;12(1):8422. doi: 10.1038/s41598-022-12548-z</mixed-citation><mixed-citation xml:lang="ru">Martin-Nunez E., Perez-Castro A., Tagua V.G., et al. Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease // Sci Rep. 2022. Vol. 12, N 1. P. 8422. doi: 10.1038/s41598-022-12548-z</mixed-citation></citation-alternatives></ref><ref id="B56"><label>56.</label><citation-alternatives><mixed-citation xml:lang="en">Liu W, Chen X, Wu M, et al. Recombinant Klotho protein enhances cholesterol efflux of THP-1 macrophage-derived foam cells via suppressing Wnt/β-catenin signaling pathway. BMC Cardiovasc Disord. 2020;20(1):120. doi: 10.1186/s12872-020-01400-9</mixed-citation><mixed-citation xml:lang="ru">Liu W., Chen X., Wu M., et al. Recombinant Klotho protein enhances cholesterol efflux of THP-1 macrophage-derived foam cells via suppressing Wnt/β-catenin signaling pathway // BMC Cardiovasc Disord. 2020. Vol. 20, N 1. P. 120. doi: 10.1186/s12872-020-01400-9</mixed-citation></citation-alternatives></ref><ref id="B57"><label>57.</label><citation-alternatives><mixed-citation xml:lang="en">Sun X, Chen L, He Y, Zheng L. Circulating α-Klotho levels in relation to cardiovascular diseases: a mendelian randomization study. Front Endocrinol (Lausanne). 2022;13:842846. doi: 10.3389/fendo.2022.842846</mixed-citation><mixed-citation xml:lang="ru">Sun X., Chen L., He Y., Zheng L. Circulating α-Klotho levels in relation to cardiovascular diseases: a mendelian randomization study // Front Endocrinol (Lausanne). 2022. Vol. 13. P. 842846. doi: 10.3389/fendo.2022.842846</mixed-citation></citation-alternatives></ref><ref id="B58"><label>58.</label><citation-alternatives><mixed-citation xml:lang="en">Navarro-Gonzalez JF, Donate-Correa J, Muros de Fuentes M, et al. Reduced Klotho is associated with the presence and severity of coronary artery disease. Heart. 2014;100(1):34–40. doi: 10.1136/heartjnl-2013-304746</mixed-citation><mixed-citation xml:lang="ru">Navarro-Gonzalez J.F., Donate-Correa J., Muros de Fuentes M., et al. Reduced Klotho is associated with the presence and severity of coronary artery disease // Heart. 2014. Vol. 100, N 1. P. 34–40. doi: 10.1136/heartjnl-2013-304746</mixed-citation></citation-alternatives></ref><ref id="B59"><label>59.</label><citation-alternatives><mixed-citation xml:lang="en">Gocer K, Aykan AC, Kilinc M, Gocer NS. Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease. Scand J Clin Lab Invest. 2020;80(4):277–281. doi: 10.1080/00365513.2020.1728786</mixed-citation><mixed-citation xml:lang="ru">Goçer K., Aykan A.C., Kilinc M., Gocer N.S. Association of serum FGF-23, klotho, fetuin-A, osteopontin, osteoprotegerin and hs-CRP levels with coronary artery disease // Scand J Clin Lab Invest. 2020. Vol. 80, N 4. P. 277–281. doi: 10.1080/00365513.2020.1728786</mixed-citation></citation-alternatives></ref><ref id="B60"><label>60.</label><citation-alternatives><mixed-citation xml:lang="en">Bergmark BA, Udell JA, Morrow DA, et al. Klotho, fibroblast growth factor-23, and the renin-angiotensin system — an analysis from the PEACE trial. Eur J Heart Fail. 2019;21(4):462–470. doi: 10.1002/ejhf.1424</mixed-citation><mixed-citation xml:lang="ru">Bergmark B.A., Udell J.A., Morrow D.A., et al. Klotho, fibroblast growth factor-23, and the renin-angiotensin system — an analysis from the PEACE trial // Eur J Heart Fail. 2019. Vol. 21, N 4. P. 462–470. doi: 10.1002/ejhf.1424</mixed-citation></citation-alternatives></ref><ref id="B61"><label>61.</label><citation-alternatives><mixed-citation xml:lang="en">Xu JP, Zeng RX, He MH, et al. Associations between serum soluble α-Klotho and the prevalence of specific cardiovascular disease. Front Cardiovasc Med. 2022;9:899307. doi: 10.3389/fcvm.2022.899307</mixed-citation><mixed-citation xml:lang="ru">Xu J.P., Zeng R.X., He M.H., et al. Associations between serum soluble α-Klotho and the prevalence of specific cardiovascular disease // Front Cardiovasc Med. 2022. Vol. 9. P. 899307. doi: 10.3389/fcvm.2022.899307</mixed-citation></citation-alternatives></ref><ref id="B62"><label>62.</label><citation-alternatives><mixed-citation xml:lang="en">Koga S, Ikeda S, Akashi R, et al. Serum soluble Klotho is inversely related to coronary artery calcification assessed by intravascular ultrasound in patients with stable coronary artery disease. J Cardiol. 2021;77(6):583–589. doi: 10.1016/j.jjcc.2020.11.014</mixed-citation><mixed-citation xml:lang="ru">Koga S., Ikeda S., Akashi R., et al. Serum soluble Klotho is inversely related to coronary artery calcification assessed by intravascular ultrasound in patients with stable coronary artery disease // J Cardiol. 2021. Vol. 77, N 6. P. 583–589. doi: 10.1016/j.jjcc.2020.11.014</mixed-citation></citation-alternatives></ref><ref id="B63"><label>63.</label><citation-alternatives><mixed-citation xml:lang="en">Abdallah E, Mosbah O, Khalifa G, et al. Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients. Kidney Res Clin Pract. 2016;35(1):42–49. doi: 10.1016/j.krcp.2015.12.006</mixed-citation><mixed-citation xml:lang="ru">Abdallah E., Mosbah O., Khalifa G., et al. Assessment of the relationship between serum soluble Klotho and carotid intima-media thickness and left ventricular dysfunction in hemodialysis patients // Kidney Res Clin Pract. 2016. Vol. 35, N 1. P. 42–49. doi: 10.1016/j.krcp.2015.12.006</mixed-citation></citation-alternatives></ref><ref id="B64"><label>64.</label><citation-alternatives><mixed-citation xml:lang="en">Kespleri EV, Polunina OS, Аkhmineeva AKh, et al. Analysis of Klotho protein level in patients with myocardial infarction and concurrent chronic obstructive pulmonary disease with different ma nifestations. Tuberculosis and Lung Diseases. 2021;99(8):27–32. (In Russ). doi: 10.21292/2075-1230-2021-99-8-27-32</mixed-citation><mixed-citation xml:lang="ru">Кесплери Э.В., Полунина О.С., Ахминеева А.Х., и др. Анализ уровня белка Клото у пациентов с инфарктом миокарда на фоне хронической обструктивной болезни легких с разными проявлениями // Туберкулез и болезни легких. 2021. Т. 99, № 8. С. 27–32. doi: 10.21292/2075-1230-2021-99-8-27-32</mixed-citation></citation-alternatives></ref><ref id="B65"><label>65.</label><citation-alternatives><mixed-citation xml:lang="en">Orces C.H. The association between serum soluble klotho levels and abdominal aorta calcification in older adults. Aging Clin Exp Res. 2022;34(6):1447–1452. doi: 10.1007/s40520-021-02053-0</mixed-citation><mixed-citation xml:lang="ru">Orces C.H. The association between serum soluble klotho levels and abdominal aorta calcification in older adults // Aging Clin Exp Res. 2022. Vol. 34, N 6. P. 1447–1452. doi: 10.1007/s40520-021-02053-0</mixed-citation></citation-alternatives></ref><ref id="B66"><label>66.</label><citation-alternatives><mixed-citation xml:lang="en">Zhou X, Li S, Wang Z, et al. Klotho protein: а potential therapeutic agent during myocardial ischemia and reperfusion. Int J Cardiol. 2015;191:227–228. doi: 10.1016/j.ijcard.2015.05.029</mixed-citation><mixed-citation xml:lang="ru">Zhou X., Li S., Wang Z., et al. Klotho protein: a potential therapeutic agent during myocardial ischemia and reperfusion // Int J Cardiol. 2015. Vol. 191. P. 227–228. doi: 10.1016/j.ijcard.2015.05.029</mixed-citation></citation-alternatives></ref><ref id="B67"><label>67.</label><citation-alternatives><mixed-citation xml:lang="en">Olejnik A, Krzywonos-Zawadzka A, Banaszkiewicz M, Bil-Lula I. Klotho protein contributes to cardioprotection during ischaemia/reperfusion injury. J Cell Mol Med. 2020;24(11):6448–6458. doi: 10.1111/jcmm.15293</mixed-citation><mixed-citation xml:lang="ru">Olejnik A., Krzywonos-Zawadzka A., Banaszkiewicz M., Bil-Lula I. Klotho protein contributes to cardioprotection during ischaemia/reperfusion injury // J Cell Mol Med. 2020. Vol. 24, N 11. P. 6448–6458. doi: 10.1111/jcmm.15293</mixed-citation></citation-alternatives></ref><ref id="B68"><label>68.</label><citation-alternatives><mixed-citation xml:lang="en">Olejnik A, Banaszkiewicz M, Krzywonos-Zawadzka A, Bil-Lula I. The Klotho protein supports redox balance and metabolic functions of cardiomyocytes during ischemia/reperfusion injury. Cardiol J. 2021. doi: 10.5603/CJ. a2021.0174</mixed-citation><mixed-citation xml:lang="ru">Olejnik A., Banaszkiewicz M., Krzywonos-Zawadzka A., Bil-Lula I. The Klotho protein supports redox balance and metabolic functions of cardiomyocytes during ischemia/reperfusion injury // Cardiol J. 2021. doi: 10.5603/CJ. a2021.0174</mixed-citation></citation-alternatives></ref><ref id="B69"><label>69.</label><citation-alternatives><mixed-citation xml:lang="en">Myung J, Beom JH, Kim JH, et al. Recombinant Klotho protein ameliorates myocardial ischemia/reperfusion injury by attenuating sterile inflammation. Biomedicines. 2022;10(4):894. doi: 10.3390/biomedicines10040894</mixed-citation><mixed-citation xml:lang="ru">Myung J., Beom J.H., Kim J.H., et al. Recombinant Klotho protein ameliorates myocardial ischemia/reperfusion injury by attenuating sterile inflammation // Biomedicines. 2022. Vol. 10, N 4. P. 894. doi: 10.3390/biomedicines10040894</mixed-citation></citation-alternatives></ref><ref id="B70"><label>70.</label><citation-alternatives><mixed-citation xml:lang="en">Qiu X, Guo Q, Xiong W, et al. Therapeutic effect of astragaloside-IV on bradycardia is involved in up-regulating klotho expression. Life Sci. 2016;144:94–102. doi: 10.1016/j.lfs.2015.11.021</mixed-citation><mixed-citation xml:lang="ru">Qiu X., Guo Q., Xiong W., et al. Therapeutic effect of astragaloside-IV on bradycardia is involved in up-regulating klotho expression // Life Sci. 2016. Vol. 144, P. 94–102. doi: 10.1016/j.lfs.2015.11.021</mixed-citation></citation-alternatives></ref><ref id="B71"><label>71.</label><citation-alternatives><mixed-citation xml:lang="en">Cheng L, Zhang L, Yang J, Hao L. Activation of peroxisome proliferator-activated receptor γ inhibits vascular calcification by upre gulating Klotho. Exp Ther Med. 2017;13(2):467–474. doi: 10.3892/etm.2016.3996</mixed-citation><mixed-citation xml:lang="ru">Cheng L., Zhang L., Yang J., Hao L. Activation of peroxisome proliferator-activated receptor γ inhibits vascular calcification by upregulating Klotho // Exp Ther Med. 2017. Vol. 13, N 2. P. 467–474. doi: 10.3892/etm.2016.3996</mixed-citation></citation-alternatives></ref><ref id="B72"><label>72.</label><citation-alternatives><mixed-citation xml:lang="en">Narumiya H, Sasaki S, Kuwahara N, et al. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells. Cardiovasc Res. 2004;64(2):331–336. doi: 10.1016/j.cardiores.2004.07.011</mixed-citation><mixed-citation xml:lang="ru">Narumiya H., Sasaki S., Kuwahara N., et al. HMG-CoA reductase inhibitors up-regulate anti-aging klotho mRNA via RhoA inactivation in IMCD3 cells // Cardiovasc Res. 2004. Vol. 64, N 2. P. 331–336. doi: 10.1016/j.cardiores.2004.07.011</mixed-citation></citation-alternatives></ref><ref id="B73"><label>73.</label><citation-alternatives><mixed-citation xml:lang="en">Youssef OM, Morsy AI, El-Shahat MA, et al. The neuroprotective effect of simvastatin on the cerebellum of experimentally-induced diabetic rats through klotho upregulation: аn immunohistochemical study. J Chem Neuroanat. 2020;108:101803. doi: 10.1016/j.jchemneu.2020.101803</mixed-citation><mixed-citation xml:lang="ru">Youssef O.M., Morsy A.I., El-Shahat M.A., et al. The neuroprotective effect of simvastatin on the cerebellum of experimentally-induced diabetic rats through klotho upregulation: an immunohistochemical study // J Chem Neuroanat. 2020. Vol. 108. P. 101803. doi: 10.1016/j.jchemneu.2020.101803</mixed-citation></citation-alternatives></ref><ref id="B74"><label>74.</label><citation-alternatives><mixed-citation xml:lang="en">Maquigussa E, Paterno JC, de Oliveira Pokorny GH, et al. Klotho and PPAR gamma activation mediate the renoprotective effect of Losartan in the 5/6 nephrectomy model. Front Physiol. 2018;9:1033. doi: 10.3389/fphys.2018.01033</mixed-citation><mixed-citation xml:lang="ru">Maquigussa E., Paterno J.C., de Oliveira Pokorny G.H., et al. Klotho and PPAR gamma activation mediate the renoprotective effect of losartan in the 5/6 nephrectomy model // Front Physiol. 2018. Vol. 9. P. 1033. doi: 10.3389/fphys.2018.01033</mixed-citation></citation-alternatives></ref><ref id="B75"><label>75.</label><citation-alternatives><mixed-citation xml:lang="en">Yoon HE, Ghee JY, Piao S, et al. Angiotensin II blockade upregu lates the expression of Klotho, the anti-ageing gene, in an experi mental model of chronic cyclosporine nephropathy. Nephrol Dial Transplant. 2011;26(3):800–813. doi: 10.1093/ndt/gfq537</mixed-citation><mixed-citation xml:lang="ru">Yoon H.E., Ghee J.Y., Piao S., et al. Angiotensin II blockade upregulates the expression of Klotho, the anti-ageing gene, in an experimental model of chronic cyclosporine nephropathy // Nephrol Dial Transplant. 2011. Vol. 26, N 3. P. 800–813. doi: 10.1093/ndt/gfq537</mixed-citation></citation-alternatives></ref><ref id="B76"><label>76.</label><citation-alternatives><mixed-citation xml:lang="en">Haussler MR, Whitfield GK, Haussler CA, et al. 1,25-Dihydroxyvitamin D and Klotho: a tale of two renal hormones coming of age. Vitam Horm. 2016;100:165–230. doi: 10.1016/bs.vh.2015.11.005</mixed-citation><mixed-citation xml:lang="ru">Haussler M.R., Whitfield G.K., Haussler C.A., et al. 1,25-Di hydro xy vitamin D and Klotho: a tale of two renal hormones coming of age // Vitam Horm. 2016. Vol. 100. P. 165–230. doi: 10.1016/bs.vh.2015.11.005</mixed-citation></citation-alternatives></ref><ref id="B77"><label>77.</label><citation-alternatives><mixed-citation xml:lang="en">Pavlov S, Nikitchenko Y, Tykhonovska М. The impact of the chemical agents of different pharmacological groups on the klotho protein concentration in the cardiomyocyte and neurocyte suspension in 120-minute hypoxia in vitro. Georgian Med News. 2020;(306): 184–188</mixed-citation><mixed-citation xml:lang="ru">Pavlov S., Nikitchenko Y., Tykhonovska М. The impact of the chemical agents of different pharmacological groups on the klotho protein concentration in the cardiomyocyte and neurocyte suspension in 120-minute hypoxia in vitro // Georgian Med News. 2020. N 306. P. 184–188</mixed-citation></citation-alternatives></ref></ref-list></back></article>
